About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 11537 record(s)
Req # A-2019-01732
Any departmental memo, report, briefing note, departmental file, letter, email to the minister regarding the export of material on the export control list by the following businesses, since 2009. Vehicles, turrets, rifles, mounted cannons, radar systems, maintenance, or training from Rheinmetall. For END USERS in any of these countries, whether or not the goods were shipped through other countries before arriving at these clients: Saudi Arabia, United Arab Emirates, Yemen, Bahrain, Egypt, Syria, Algeria, Libya, Morocco, Philippines, Jordan.Organization: Global Affairs Canada
January 2020
Req # A-2019-00747
Communication plans regarding relations between Canada and China AND regarding Huawei AND regarding the United States extradition request for Huawei executive Meng Wanzhou, between January 1 and June 12, 2019.Organization: Global Affairs Canada
January 2020
Req # A-2018-000950
Any one document that provides the batch number(s) of all REVLIMID used in the comparative studies included in the APO-LENALIDOMIDE abbreviated new drug submission number 218298.Organization: Health Canada
January 2020
Req # A-2019-001678
Records regarding the use of electroconvulsive therapy by Canadian government institutions during the years 2010-2018.Organization: Health Canada
January 2020
Req # A-2019-000752
Health Canada Compliance report delivered to CannTrust.Organization: Health Canada
January 2020
Req # A-2019-000521
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-106665-371.Organization: Health Canada
January 2020
Req # A-2019-001374
Any New Drug Submission (NDS), regarding new drugs containing ferric carboxymaltose, also named iron carboxymaltose or iron dextri-maltose: - The related exchanges between Health Canada and the sponsor and the minutes and presentation materials of any meeting between Health Canada and the sponsor.Organization: Health Canada
January 2020
Req # A-2019-001587
All correspondence with Nova Scotia’s Department of Fisheries and Aquaculture (“DFA”) with respect to aquaculture applications for new and expanded salmon farming sites in Liverpool Bay, NS.Organization: Health Canada
January 2020
Req # A-2019-001544
An Abbreviated New Drug Submission(s) (ANDS) and/or a New Drug Submission (NDS) seeking approval of a product containing the medicinal ingredient insulin as part based on the use of FIASP® as the Canadian Reference Product.Organization: Health Canada
January 2020
Req # A-2019-001576
All records detailing what was discussed at each meeting of the Deputy Ministers Task Force on Public Sector Innovation (TF-PSI) committee over the past six months.Organization: Health Canada
January 2020